There are changes on the horizon concerning Canada’s medical marijuana laws. Canada is transitioning from the current Marijuana for Medical Access Program (MMAR) to the Marijuana for Medical Purposes Regulations (MMPR). The Government has transferred production and distribution of marijuana for medicinal purposes to companies that have met security requirements.

 

These changes have spurred a growth of over 40 new publicly traded Canadian Cannabis companies that are all entering this new growth industry. The recent IPO Tweed Marijuana Inc. is trading at 7x’s valuation in the $3.00 ange.

 

Health Canada estimates that the emerging medical marijuana market to be in excess of $1 billion. Stephen Easton, an SFU Economist, estimated that nationally the Cannabis industry generates approximately $19 to $21 billion.

 

Cannabis Investor is a website dedicated to publicly traded Canadian Cannabis Companies.

 

Don’t miss the out on the news & trading opportunities, visit and sign up for free alerts.